[1] Rainsford KD. Ibuprofen: from invention to an OTC therapeutic mainstay [J]. Int J Clin Pract, 2013, 67(s178):9-20.
[2] McGeer PL, McGeer EG. NSAIDs and Alzheimer disease:epidemiological, animal model and clinical studies [J].Neurobiol Aging, 2007, 28(5): 639-647.
[3] Weggen S, Rogers M, Eriksen J. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? [J]. Neurobiol Aging, 2007, 28(10):536-543.
[4] Ait Ouakrim D, Dashti SG, Chau R, et al. Aspirin, ibuprofen,and the risk for colorectal cancer in Lynch syndrome [J]. J Natl Cancer Inst, 2016, 108(2): djv384.
[5] Janakiram NB, Mohammed A, Lang ML, et al. Immune modulation by agents used in the prevntion and treatment of colon and pancreatic cancers. in cancer immunology [M].Berlin: Springer Berlin Heidelberg, 2015: 249-275.
[6] Chandrasekharan NV, Dai H, Roos KLT, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression [J]. Proc Natl Acad Sci USA, 2002, 99(21):13926-13931.
[7] Warner TD, Giuliano F, Vojnovic I, et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis [J]. Proc Natl Acad Sci USA,1999, 96(13): 7563-7568.
[8] Flower RJ. The development of COX2 inhibitors [J]. Nat Rev Drug Discov, 2003, 2(3): 179-191.
[9] Buttgereit F, Burmester GR, Simon LS. Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors [J]. Am J Med, 2001,110(3): 13-19.
[10] Wallace JL. Selective COX-2 inhibitors: is the water becoming muddy? [J]. Neurobiol Aging, 1999, 20(1): 4-6.
[11] Nichol KJ, Allen DW. The medicinal chemistry of ibuprofen.in. Ibuprofen: Discovery, development and therapeutics [M].New York: John Wiley & Sons Ltd., 2015: 22-50.
[12] Mittal S, Malde A, Selvam C, et al. Synthesis and evaluation of S-4-(3-thienyl)phenyl-α-methylacetic acid [J]. Bioorg Med Chem Lett, 2004, 14(4): 979-982.
[13] 郭长彬, 陈晓红, 易 翔, 等. 布洛芬衍生物的合成及抗炎镇痛活性[J]. 化学学报, 2005, 63(9): 841-848.
[14] Sujith KV, Rao JN, Shetty P, et al. Regioselective reaction:synthesis and pharmacological study of Mannich bases containing ibuprofen moiety [J]. Eur J Med Chem, 2009,44(9): 3697-3702.
[15] Maxwell JR, Wasdahl DA, Wolfson AC, et al. Synthesis of 5-aryl-2H-tetrazoles, 5-aryl-2H-tetrazole-2-acetic acids, and [(4-phenyl-5-aryl-4H-1,2,4-triazol-3-yl)thio]acetic acids as possible superoxide scavengers and antiinflammatory agents [J]. J Med Chem, 1984, 27(12): 1565-1570.
[16] Ashok M, Holla BS, Poojary B. Convenient one pot synthesis and antimicrobial evaluation of some new Mannich bases carrying 4-methylthiobenzyl moiety [J]. Eur J Med Chem,2007, 42(8): 1095-1101.
[17] Uzg?ren-Baran A, Tel BC, Sar?g?l D, et al. Thiazolo[3,2-b]-1,2,4-triazole-5(6H)-one substituted with ibuprofen:novel non-steroidal anti-inflammatory agents with favorable gastrointestinal tolerance [J]. Eur J Med Chem, 2012, 57:398-406.
[18] Bansal Y, Kaur M, Silakari O. Benzimidazole-ibuprofen/mesalamine conjugates: potential candidates for multifactorial diseases [J]. Eur J Med Chem, 2015, 89: 671-682.
[19] Lassalas P, Oukoloff K, Makani V, et al. Evaluation of oxetan-3-ol, thietan-3-ol, and derivatives thereof as bioisosteres of the carboxylic acid functional group [J]. ACS Med Chem Lett, 2017, 8(8): 864-868.
[20] Khan MS, Akhter M. Synthesis, pharmacological activity and hydrolytic behavior of glyceride prodrugs of ibuprofen [J].Eur J Med Chem, 2005, 40(4): 371-376.
[21] Katritzky AR, Jishkariani D, Narindoshvili T. Convenient synthesis of ibuprofen and naproxen aminoacyl, dipeptidoyl and ester derivatives [J]. Chem Biol Drug Des, 2009, 73(6):618-626.
[22] Zhao X, Chen D, Gao P, et al. Synthesis of ibuprofen eugenol ester and its microemulsion formulation for parenteral delivery [J]. Chem Pharm Bull, 2005, 53(10): 1246-1250.
[23] Uhrig RK, Picard MA, Beyreuther K, et al. Synthesis of antioxidative and anti-inflammatory drugs glucoconjugates[J]. Carbohydr Res, 2000, 325(1): 72-80.
[24] Zhao X, Tao X, Wei D, et al. Pharmacological activity and hydrolysis behavior of novel ibuprofen glucopyranoside conjugates [J]. Eur J Med Chem, 2006, 41(11): 1352-1358.
[25] Chen Q, Gong T, Liu J, et al. Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery [J]. J Drug Target, 2009,17(4): 318-328.
[26] Duan Y, Yu J, Liu S, et al. Synthesis of anthraquinoneibuprofen prodrugs with hydroxyapatite affinity and anti-inflammatory activity characteristics [J]. Med Chem, 2009,5(6): 577-582.
[27] Zhao Y, Qu B, Wu X, et al. Design, synthesis and biological evaluation of brain targeting l-ascorbic acid prodrugs of ibuprofen with “lock-in” function [J]. Eur J Med Chem,2014, 82: 314-323.
[28] Xin G, Wang Y, Guo X, et al. Synthesis of diosgeninibuprofen derivatives and their activities against insulindependent diabetes mellitus [J]. Chem Pharm Bull, 2013,61(5): 532-538.
[29] Banekovich C, Ott I, Koch T, et al. Synthesis and biological activities of novel dexibuprofen tetraacetylriboflavin conjugates [J]. Bioorg Med Chem Lett, 2007, 17(3): 683-687.
[30] Theodosis-Nobelos P, Tziona P, Poptsis A, et al. Novel polyfunctional esters of ibuprofen and ketoprofen with hypolipidemic, lipoxygenase inhibitory and enhanced anti-inflammatory activity [J]. Med Chem Res, 2017, 26(2): 461-472.
[31] Saeed A, Channar PA, Larik FA, et al. Design, synthesis,molecular docking studies of organotin-drug derivatives as multi-target agents against antibacterial, antifungal,α-amylase, α-glucosidase and butyrylcholinesterase [J].Inorg Chim Acta, 2017, 464: 204-213.
[32] Ingram MJ, Moynihan HA, Powell MW, et al. Synthesis and hydrolytic behaviour of glycerol-1,2-diibuprofenate-3-nitrate, a putative pro-drug of ibuprofen and glycerol-1-nitrate [J]. J Pharm Pharmacol, 2001, 53(3): 345-350.
[33] Sarkate AP, Lokwani DK, Patil AA, et al. Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenicity and nitric oxide-releasing studies of novel ibuprofen analogs as nonulcerogenic derivatives [J]. Med Chem Res, 2011,20(7): 795-808.
[34] Borhade N, Pathan AR, Halder S, et al. NO-NSAIDs. Part 3: nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs [J]. Chem Pharm Bull(Tokyo), 2012,60(4): 465-481.
[35] Lolli ML, Cena C, Medana C, et al. A new class of ibuprofen derivatives with reduced gastrotoxicity [J]. J Med Chem,2001, 44(21): 3463-3468.
[36] Velázquez C, Praveen Rao PN, Knaus EE. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies [J]. J Med Chem,2005, 48(12): 4061-4067.
[37] Velázquez CA, Praveen Rao NP, Citro ML, et al. O2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs(NONO-NSAIDs): Synthesis, nitric oxide release, and biological evaluation studies [J]. Bioorg Med Chem, 2007,15(14): 4767-4774.
[38] Huang Z, Velázquez CA, Abdellatif KRA, et al.Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs(NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, antiinflammatory,and ulcerogenicity index studies [J]. J Med Chem, 2011, 54(5): 1356-1364.
[39] Cocco MT, Congiu C, Onnis V, et al. Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties [J]. Eur J Med Chem, 2003, 38(5):513-518.
[40] Ahmadi A, Khalili M, Olama Z, et al. Synthesis and study of analgesic and anti-inflammatory activities of amide derivatives of ibuprofen [J]. Mini-Rev Med Chem, 2017,17(9): 799-804.
[41] Chatterjee NR, Kulkarni AA, Ghulekar SP. Synthesis,pharmacological activity and hydrolytic behavior of ethylenediamine and benzathine conjugates of ibuprofen [J].Eur J Med Chem, 2008, 43(12): 2819-2823.
[42] Siskou IC, Rekka EA, Kourounakis AP, et al. Design and study of some novel ibuprofen derivatives with potential nootropic and neuroprotective properties [J]. Bioorg Med Chem, 2007, 15(2): 951-961.
[43] Gundogdu-Hizliates C, Alyuruk H, Gocmenturk M, et al.Synthesis of new ibuprofen derivatives with their in silico and in vitro cyclooxygenase-2 inhibitions [J]. Bioorg Chem,2014, 52(2): 8-15.
[44] Al-Mekhlafi S, Alkadi H, El-Sayed MIK. Synthesis and anti-inflammatory activity of novel ketoprofen and ibuprofen derivatives [J]. J Chem Pharm Res, 2015, 7: 503-510.
[45] Bua S, Di CML, Vullo D, et al. Design and synthesis of novel nonsteroidal anti-inflammatory drugs and carbonic anhydrase inhibitors hybrids(NSAIDs-CAIs) for the treatment of rheumatoid arthritis [J]. J Med Chem, 2017, 60(3): 1159-1170.
[46] Davaran S, Entezami AA. Acrylic type polymers containing ibuprofen and indomethacin with difunctional spacer group:synthesis and hydrolysis [J]. J Controlled Release, 1997,47(1): 41-49.
[47] Babazadeh M. Synthesis and study of controlled release of ibuprofen from the new acrylic type polymers [J]. Int J Pharm, 2006, 316(1): 68-73.
[48] Cai X, Wang N, Lin X. Chemo-enzymatic synthesis of optically active polymeric prodrug of naproxen, ketoprofen and ibuprofen [J]. Polymer, 2006, 47(19): 6491-6495.
[49] Davaran S, Rashidi MR, Hanaee J, et al. Synthesis and hydrolytic behavior of ibuprofen prodrugs and their PEGylated derivatives [J]. Drug deliv, 2006, 13(5): 383-387.
[50] París R, García JM, Quijada-Garrido I. Synthesis and characterization of a new acrylic polymeric ibuprofen prodrug [J]. J Appl Polym Sci, 2010, 117(6): 3271-3276.
[51] Babazadeh M. Design, synthesis and in vitro evaluation of vinyl ether type polymeric prodrugs of ibuprofen, ketoprofen and naproxen [J]. Int J Pharm, 2008, 356(1): 167-173.
[52] Kurz M, Scriba GK. Drug-phospholipid conjugates as potential prodrugs: synthesis, characterization, and degradation by pancreatic phospholipase A2 [J]. Chem Phys Lipids, 2000, 107(2): 143-157.
[53] Xie G, Sun Y, Nie T, et al. Phospho-ibuprofen(MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models [J]. J Pharmacol Exp Ther, 2011, 337(3): 876-886.
[54] Huang L, Mackenzie GG, Ouyang N, et al. The novel phospho-non-steroidal anti-inflammatory drugs, OXT-328,MDC-22 and MDC-917, inhibit adjuvant-induced arthritis in rats [J]. Br J Pharmacol, 2011, 162(7): 1521-1533.
[55] Wong CC, Cheng KW, Xie G, et al. Carboxylesterases 1 and 2 hydrolyze phospho-nonsteroidal anti-inflammatory drugs:relevance to their pharmacological activity [J]. J Pharmacol Exp Ther, 2012, 340(2): 422-432.
[56] Nie T, Wong CC, Alston N, et al. Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo [J]. Br J Pharmacol, 2012, 166(3): 991-1001.
[57] Mattheolabakis G, Nie T, Constantinides PP, et al. Sterically stabilized liposomes incorporating the novel anticancer agent phospho-ibuprofen (MDC-917): preparation,characterization, and in vitro/in vivo evaluation [J]. PharmRes, 2012, 29(6): 1435-1443.
[58] 程 铃, 钱 珊, 樊 维, 等. 布洛芬—偕二膦酸偶联物的合成及体外靶向性研究[J]. 四川大学学报(自然科学版),2011, 48(4): 891-894.
[59] Bikzhanova GA, Toulokhonova IS, Gately S, et al. Novel silicon-containing drugs derived from the indomethacin scaffold: Synthesis, characterization and evaluation of biological activity [J]. Silicon Chem, 2007, 3(3-4): 209-217.
[60] Pérez DJ, Díaz-Reval MI, Obledo-Benicio F, et al. Silicon containing ibuprofen derivatives with antioxidant and anti-inflammatory activities: An in vivo and in silico study [J].Eur J Pharmacol, 2017, 814: 18-27.
[61] Pérez DJ, Zakai UI, Guo S, et al. Synthesis and biological screening of silicon-containing ibuprofen derivatives: a study of their NF-kβ inhibitory activity, cytotoxicity, and their ability to bind IKKβ [J]. Aust J Chem, 2015, 69(6): 662-671.
[62] Song F, Salter R, Chen L. Development of decarboxylative cyanation Reactions for C-13/C-14 carboxylic acid labeling using an electrophilic cyanating reagent [J]. J Org Chem,2017, 82(7): 3530-3537.
[63] Capaldo L, Buzzetti L, Merli D, et al. Smooth photocatalyzed benzylation of electrophilic olefins via decarboxylation of arylacetic acids [J]. J Org Chem, 2016, 81(16): 7102-7109.
[64] Lang SB, Cartwright KC, Welter RS, et al. Photocatalytic aminodecarboxylation of carboxylic acids [J]. European J Org Chem, 2016, 2016(20): 3331-3334.
[65] Huang X, Liu W, Hooker JM, et al. Targeted fluorination with the fluoride ion by manganese-catalyzed decarboxylation [J].Angew Chem Int Ed Engl, 2015, 54(17): 5241-5245.
[66] McNeill E, Du Bois J. Catalytic C-H oxidation by a triazamacrocyclic ruthenium complex [J]. Chem Sci, 2012,3(6): 1810-1813.
[67] Liang YF, Jiao N. Highly efficient C-H hydroxylation of carbonyl compounds with oxygen under mild conditions [J].Angew Chem Int Ed Engl, 2014, 126(2): 558-562.
[68] Nagib DA, MacMillan DWC. Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis [J].Nature, 2011, 480(7376): 224-228.